Women’s hormone replacement left out of military 'High-T' guidance
The Department of War finalized clinical guidance for testosterone screening for male service members, but left out similar best practices for treating women in the military for hormone disruptions that might affect performance.
TL;DR
- The Department of War finalized clinical guidance for testosterone screening for male service members.
- The Pentagon withdrew initial hormone replacement protocols for both men and women.
- New guidance focuses on male service members, omitting best practices for treating women's hormone disruptions.
- The decision might affect military performance by not addressing female service members' hormonal health.